Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-028992
Filing Date
2025-02-27
Accepted
2025-02-27 16:00:24
Documents
76
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K crdf-20241231.htm   iXBRL 10-K 2307620
2 EX-19.1 crdf-ex19_1.htm EX-19.1 215310
3 EX-23.1 crdf-ex23_1.htm EX-23.1 4988
4 EX-31.1 crdf-ex31_1.htm EX-31.1 14128
5 EX-31.2 crdf-ex31_2.htm EX-31.2 14009
6 EX-32.1 crdf-ex32_1.htm EX-32.1 7974
7 EX-32.2 crdf-ex32_2.htm EX-32.2 7855
8 GRAPHIC img97750619_0.jpg GRAPHIC 99637
  Complete submission text file 0000950170-25-028992.txt   10418592

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crdf-20241231.xsd EX-101.SCH 1113743
79 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20241231_htm.xml XML 2065010
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35558 | Film No.: 25678485
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)